REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Humax Pharmaceutical S.A. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Humax Pharmaceutical S.A. Profile Updated: July 20, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Leader in the research, development and commercialization of specialized products, of high-cost diseases and of vital diseases that are not available, and additionally leader in pharmaceutical treatment programs that facilitate the proper use of medicines.

Headquarters
Cl 97B Sur # 50 95
La Estrella; Antioquia;

Contact Details: Purchase the Humax Pharmaceutical S.A. report to view the information.

Website: http://www.humax.com.co

Basic Information
Total Employees:
Purchase the Humax Pharmaceutical S.A. report to view the information.
Registered Capital:
Purchase the Humax Pharmaceutical S.A. report to view the information.
Financial Auditors:
Purchase the Humax Pharmaceutical S.A. report to view the information.
Incorporation Date:
February 11, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Company Performance
Financial values in the chart are available after Humax Pharmaceutical S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
5.4%▲
Total Operating Revenue
5.13%▲
Operating Profit
-93.15%▼
EBITDA
-30.1%▼
Net Profit/Loss for the Period
N/A
Total Assets
42%▲
Total Equity
38.97%▲
Operating Profit Margin
-0.43%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
2611%▲
Quick Ratio
-352.95%▼
Cash Ratio
0.02%▲

Similar companies

Droguerias Y Farmacias Cruz Verde S.A.S
 
Tecnoquimicas S.A.
Bayer S A
 
Merck Sharp & Dohme Colombia S.A.S
Procaps S.A.
 
Novartis De Colombia S A
Laboratorios Legrand S A
 
Laboratorios Ecar S.A.
Eurofarma Colombia Sas
 
Jgb S.A.
Coaspharma Sas
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo